Norah G. Verbout

1. Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial
   2019/01/31 by Christina U. Lorentz, Norah G. Verbout, Michael Wallisch +9 · 1 citation
   Medicine · #Coagulation, Bradykinin, Polyphosphates, and Angioedema #Blood Coagulation and Thrombosis Mechanisms #Hemophilia Treatment and Research